Find a Doctor

PL
Areas of Expertise

Peter E. Lipsky

Rilite Research Institute
Rheumatology, Internal Medicine
Male

Bio

Peter Lipsky is an Internal Medicine specialist and a Rheumatologist in Charlottesville, Virginia. He has been an author on 170 peer reviewed articles in the past 15 years. He is licensed to treat patients in MD.

Areas of Expertise

Contact

1545 London Rd
Charlottesville, VA 22901, US

434-293-6526

Latest Advances

Latest Advance
Study
  • Condition: Chronic Refractory Gout
  • Journal: Seminars in arthritis and rheumatism
  • Treatment Used: Pegloticase
  • Number of Patients: 0
  • Published —
This article discusses pegloticase treatment of chronic refractory gout.
Latest Advance
Study
  • Condition: Chronic Refractory Gout
  • Journal: The Journal of rheumatology
  • Treatment Used: Pegloticase
  • Number of Patients: 128
  • Published —
This study assessed the benefit of pegloticase in patients with chronic refractory gout.
Latest Advance
Study
  • Condition: Chronic Gout
  • Journal: Hypertension (Dallas, Tex. : 1979)
  • Treatment Used: Pegloticase
  • Number of Patients: 173
  • Published —
In this study, researchers evaluated the outcomes of taking pegloticase for the treatment of high blood pressure in persons with chronic gout.
Latest Advance
Study
  • Condition: Systemic Lupus Erythematosus
  • Journal: Lancet (London, England)
  • Treatment Used: Ustekinumab
  • Number of Patients: 102
  • Published —
The purpose of the study was to assess the effectiveness and safety of ustekinumab for the treatment of systemic lupus erthematosus in patients with moderate-to severe disease activity despite conventional treatment
Latest Advance
Study
  • Condition: Early Inflammatory Arthritis
  • Journal: Arthritis research & therapy
  • Treatment Used: Infliximab plus Methotrexate
  • Number of Patients: 99
  • Published —
This study explored the effects of immediate induction therapy with the anti-tumour necrosis factor (TNF)? antibody infliximab (IFX) plus methotrexate (MTX) compared with MTX alone and with placebo (PL) in patients with very early inflammatory arthritis.
Latest Advance
Study
  • Condition: Rheumatoid Arthritis
  • Journal: Arthritis research & therapy
  • Treatment Used: Tripterygium wilfordii Hook F
  • Number of Patients: 207
  • Published —
The objective of this study is to compare Tripterygium wilfordii Hook F alone or in combination with methotrexate in controlling the manifestations in subjects with disease-modifying antirheumatic drug (DMARD)-naïve active rheumatoid arthritis over a 6-month period.

Clinical Trials

This doctor has not participated in any recent clinical trials.

All Publications
View All

Publication
Conference
  • Sponsor: American College of Rheumatology (ACR)
  • Event Name: American College of Rheumatology Annual Scientific Meeting 2020
  • Published —
Readmission Risk and Quality of Care in Patients Presenting to the Emergency Department with Gout Flares
Publication
Conference
  • Sponsor: American College of Rheumatology (ACR)
  • Event Name: American College of Rheumatology Annual Scientific Meeting 2020
  • Published —
The Impact of Azathioprine on the Frequency of Persistent Responsiveness to Pegloticase in Patients with Chronic Refractory Gout

Contact

1545 London Rd
Charlottesville, VA 22901, US

434-293-6526

Credentials

  • Licenses
    Internal Medicine in MD

Insurance

Contact them to find out if they accept your insurance plan.